Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.16908 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Ji-Hoon Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kyung Hee University Hospital at Gang-dong, Kyung Hee University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Purines, Pyrazoles, Sulfonamides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Background
Little real‐world experience regarding the use of baricitinib, an oral selective JAK1/JAK2 inhibitor, for treating moderate to severe atopic dermatitis (AD) has been reported.
Methods
This study aimed to assess the overall outcomes in Korean patients with AD treated with baricitinib. All patients with moderate to severe AD treated with baricitinib between June 2021 and June 2022 were included, and their cases were retrospectively analyzed using medical records. Patients with moderate to severe AD, aged ≥18 years who had failed previous therapies, including those who demonstrated unsatisfactory improvement with dupilumab, were prescribed baricitinib. Patients whose follow‐up period was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Kyung Hee University Hospital at Gang-dong, Kyung Hee University School of Medicine, Seoul, Korea.
ORCID-Profile: Ji-Hoon Lim, Soon-Hyo Kwon, Bark-Lynn Lew
Zitieren
APA
Lim, J. H., Kwon, S. H., & Lew, B. L. (2024). Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab. International Journal of Dermatology. https://doi.org/10.1111/ijd.16908
Vancouver
Lim JH, Kwon SH, Lew BL. Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab. International Journal of Dermatology. 2024. doi:10.1111/ijd.16908
BibTeX
@article{Lim2024,
author = {Lim, Ji-Hoon and Kwon, Soon-Hyo and Lew, Bark-Lynn},
title = {Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.16908}
}
EUVIMED